TotalSeq™-A0830 anti-human CD319 (CRACC) Antibody, CD319, 162.1,BioLegend,331821

Host

Mouse

Reactivity

Human

Application

PG -Quality tested

Platform ID

BAB354575453

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-A0830 anti-human CD319 (CRACC) Antibody, CD319, 162.1
Cat. No.331821
HostMouse
RRIDAB_2800872 (BioLegend Cat. No. 331821)
IsotypeMouse IgG2b, κ
ReactivityHuman
ApplicationPG -Quality tested
ClonalityMonoclonal
Clone Number162.1
Concentration0.5 mg/ml
TargetCD319
ImmunogenCRACC-Human IgG1 fusion protein
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-A oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD319 is a single-pass type l transmembrane glycoprotein, expressed on NK cells, subsets of mature dendritic cells, activated B cells, and cytotoxic lymphocytes, but not in promyelocytic, B or T cell lines. Expression is highest in the spleen, lymph nodes, and peripheral blood leukocytes, and lowest in bone marrow. Additionally, it is expressed in the small intestine, stomach, appendix, lung, and trachea. CD319 is tyrosine phosphorylated in activated NK cells and is associated with 19 and 39 kD proteins. CD319 has homology with the CD2 family of receptors within the Ig superfamily. Some of the CD2 members stimulate cytotoxicity through the CD319 associated protein.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.